HACKENSACK UNIVERSITY MEDICAL CENTER is a 779-bed hospital in NJ with $1996M in annual net patient revenue. Denial rate of 0.0% presents a clear RCM improvement opportunity.

The primary value creation thesis centers on denial rate reduction from 0.0% to the industry target of 8%. Based on our analysis, this represents an estimated $0.0M in annual recoverable revenue.

Key risks include payer contract concentration, labor market tightness for medical coders, and regulatory uncertainty around Medicare reimbursement rates. See the pressure test and challenge solver for downside scenarios.

Recommend proceeding to Phase 2 diligence with focus on payer-level denial breakdown, coding accuracy assessment, and management team evaluation.